Manglam Global Q1FY26 profit up 611% with ₹10.25 issue

Key developments in one board cycle

Manglam Global Corporations Ltd reported its quarterly performance for the period ended June 30, 2026 and paired the update with a fund-raising proposal through a preferential allotment. The company later issued a clarification to correct a typographical error related to the preferential issue price. The Board’s decisions, and the follow-up clarification, put focus on both near-term financial performance and the capital-raising plan. A shareholder vote is scheduled through an Extraordinary General Meeting (EGM) in September 2026. The set of disclosures also includes meeting logistics and the intended investor mix for the preferential allotment. Together, these items form the core of what investors are tracking in the counter.

Q1FY26 results: profit surge on reported revenue

For Q1FY26 on a standalone basis, Manglam Global Corporations posted a net profit of ₹0.1558 crore. The company said the profit was up 611% year-on-year. Standalone revenue for the quarter was reported at ₹14.4082 crore. The profit figure and the revenue number were disclosed alongside the board actions on fund raising. The company also stated that the Board approved consolidated and standalone financial results for the quarter ended June 30, 2026. The quarterly numbers provide the financial backdrop against which the preferential issue is being proposed.

Preferential issue approved: size, price, and structure

The Board approved raising funds via preferential allotment of up to 1 crore equity shares. The face value of the equity shares is ₹10 each. The offer price was confirmed at ₹10.25 per share. At that price, the proposed issuance implies a gross fund raise of about ₹10.25 crore, based on the maximum number of shares indicated. The company stated the allotment is proposed to both promoters and non-promoters. The preferential issue remains subject to required regulatory and shareholder approvals as indicated in the board agenda disclosures.

Clarification: ₹10.25 confirmed after typographical error

On August 17, 2026, the company issued a clarification on the issue price for the preferential allotment. It said an inadvertent typographical error in an earlier submission mentioned ₹10.00 instead of ₹10.25 per equity share. The clarification confirmed the correct price as ₹10.25. The company also stated that all other terms and conditions of the preferential issue remain unchanged. This clarification matters because preferential issue pricing is a core input for investor evaluation, including dilution considerations and the total fund-raise amount. The correction also aligns the disclosed price across the company’s submissions.

Proposed allotment mix: promoters and a set of investors

The disclosure indicates the preferential allotment is proposed to promoters and non-promoters. Promoters Rohit Agrawal and Rahul Agrawal are slated to receive 38,15,000 shares each. The remaining shares are allocated to various non-promoter investors, including Hitesh Kumar Paliwal, Vinay Agrawal, and others, with the non-promoter list totaling 25 investors. The company has not changed these terms while issuing the price clarification. The stated split provides visibility on who is expected to participate, subject to approvals. It also signals that the transaction is not limited to promoter participation.

Board meeting and EGM: dates, timing, and mode

A Board meeting was scheduled for Friday, August 14, 2026 at 4:00 p.m. The venue disclosed was the registered office at Mangalwara Bazaar, next to Agrawal Readymade Stores, Piparia, Hoshangabad, Madhya Pradesh, India, 461775. The agenda included taking on record the unaudited financial results for the quarter ended June 30, 2026 along with the limited review report. Directors were also set to consider and approve the draft notice of an EGM. The EGM was proposed to be held on September 16, 2026 via Video Conferencing (VC) or Other Audio Visual Means (OAVM). The agenda also included appointing an e-voting scrutinizer.

Other corporate actions and financing items disclosed

Separate disclosures in the provided text also referenced capital and financing actions. The company’s authorised share capital was increased from ₹15 crore to ₹20 crore. Its wholly owned subsidiary, Shri Krishnam Industries Private Limited, had its authorised share capital increased from ₹0.70 crore to ₹10 crore. The same set of details also mentions warehouse receipt (WHR) financing of ₹25 crore, split as ₹10 crore from Central Bank of India and ₹15 crore from Aryadhan Financial Solutions. It also mentions an ECLGS 5.0 loan of ₹0.92 crore from State Bank of India. In addition, a related party purchase of ₹7.84 crore from Shri Satguru Agromills Private Limited was noted.

Key facts table: results, issue terms, and dates

Why the disclosures matter for investors

First, the Q1FY26 standalone profit growth figure of 611% year-on-year is a headline number that draws attention, but it sits alongside a relatively small absolute profit base of ₹0.1558 crore. Second, the preferential issue price correction reduces ambiguity around the fund-raise math and ensures investors are working with the same per-share price across filings. Third, the proposed allotment includes both promoters and 25 non-promoter investors, which is relevant for tracking ownership changes post-allotment. Finally, the need for shareholder approval at the September 16, 2026 EGM sets the immediate timeline for the transaction’s next milestone.

Conclusion: next step is the September 16 vote

Manglam Global Corporations’ latest disclosures combine Q1FY26 results with a preferential issue plan priced at ₹10.25 per share, after correcting a prior typographical error. The company has laid out the timeline through the August 14, 2026 board meeting and the proposed September 16, 2026 EGM via VC/OAVM. Shareholder approval at the EGM is the next confirmed step for the preferential allotment to move forward. Investors will likely track the EGM outcome and any subsequent allotment-related filings consistent with the disclosed terms.